OptiCept Technologies (OPTI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Nov, 2025Executive summary
Achieved positive EBITDA for Q3 2025, marking a significant milestone in the transition to a profitable growth company.
Strong sales in the olive oil segment, with expansion into juice and avocado oil markets.
Cost reductions and increased production efficiency have improved margins and competitiveness.
Strategic partnerships and new product launches are driving commercial progress.
Financial highlights
Net sales for Q3 2025 reached SEK 19.8 million, up from SEK 3.9 million year-over-year.
Total revenue for Q3 2025 was SEK 24.4 million, compared to SEK 6.3 million in Q3 2024.
EBITDA for Q3 2025 was SEK 54 thousand, a turnaround from SEK -9.9 million in Q3 2024.
Net result for Q3 2025 was SEK -4.1 million, improved from SEK -13.2 million in Q3 2024.
Cash flow from operating activities for Q3 2025 was SEK -9.7 million.
Outlook and guidance
Targeting positive EBITDA for the full year 2026, based on current business plan and commercial pipeline.
Continued focus on the olive oil segment, with expected revenue seasonality.
Expansion into juice, avocado oil, and solid food segments anticipated to drive growth.
Latest events from OptiCept Technologies
- Record Q2 sales and orders, narrowed losses, and major new contracts drive global expansion.OPTI
Q2 2024 - FPS deal secures SEK 150M revenue; cost cuts and financing conversions support H2 2026 profitability.OPTI
Q1 2026 - Global licensing deal with FPS secures future revenues and enables a shift to innovation-led growth.OPTI
Q4 2025 - Yield-boosting tech and new partnerships fuel growth and positive EBITDA prospects for 2026.OPTI
DNB Carnegie Småbolagsdag - Strong order intake and new financing drive expansion despite lower sales and earnings.OPTI
Q2 2025 - Revenue up, losses down, and new funding to accelerate global commercialization.OPTI
Q3 2024 - Strong Q1 growth, breakthrough orders, and new financing position OptiCept for expansion.OPTI
Q1 2025 - Revenue growth, improved margins, and new partnerships drive optimism for 2025.OPTI
Q4 2024